Literature DB >> 26786174

Self-efficacy, pros, and cons as variables associated with adjacent stages of change for regular exercise in Japanese college students.

Satoshi Horiuchi1, Akira Tsuda2, Hisanori Kobayashi3, Elizabeth A Fallon4, Yuji Sakano5.   

Abstract

This study examined self-efficacy (confidence to exercise), pros (exercise's advantages), and cons (exercise's disadvantages) as variables associated across the transtheoretical model's six stages of change in 403 Japanese college students. A series of logistic regression analyses were conducted. Results showed that higher pros and lower cons were associated with being in contemplation compared to precontemplation. Lower cons were associated with being in preparation compared to contemplation. Higher self-efficacy was associated with being in action compared to preparation as well as being in maintenance compared to action. Lower cons were associated with being in termination compared to maintenance.

Keywords:  cons; exercise behavior; pros; self-efficacy; transtheoretical model

Mesh:

Year:  2016        PMID: 26786174     DOI: 10.1177/1359105315621779

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  3 in total

1.  Processes of change, pros, cons, and self-efficacy as variables associated with stage transitions for effective stress management over a month: a longitudinal study.

Authors:  Ke Deng; Akira Tsuda; Satoshi Horiuchi; Shuntaro Aoki
Journal:  BMC Psychol       Date:  2022-05-12

2.  Persistent effect at 30-month post intervention of a community-based randomized trial of KM2H2 in reducing stroke and heart attack among senior hypertensive patients.

Authors:  Jie Gong; Yunan Xu; Xinguang Chen; Niannian Yang; Fang Li; Yaqiong Yan
Journal:  Int J Behav Nutr Phys Act       Date:  2018-01-02       Impact factor: 6.457

3.  Reliability and validity of the Japanese treatment self-regulation questionnaire for Japanese workers.

Authors:  Kayoko Ishii; Kumiko Morita; Hiroko Sumita
Journal:  BMC Public Health       Date:  2022-10-11       Impact factor: 4.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.